Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
University Hospital, Ghent
Rutgers, The State University of New Jersey
Celgene
Celgene
Ohio State University Comprehensive Cancer Center
University of California, San Francisco